Trypanosomiasis, African
Trypanosoma brucei gambiense
Melarsoprol
Trypanocidal Agents
Trypanosoma brucei rhodesiense
Trypanosoma brucei brucei
Trypanosoma
Tsetse Flies
Trypanosoma congolense
Trypanosoma vivax
Angola
Democratic Republic of the Congo
Pentamidine
Congo
Central Nervous System Protozoal Infections
Eflornithine
Insect Control
Chagas Disease
Central African Republic
Trypanosoma cruzi
Suramin
Benzamidines
Neglected Diseases
Africa, Central
Parasitic Sensitivity Tests
Variant Surface Glycoproteins, Trypanosoma
Agglutination Tests
Insect Vectors
Cote d'Ivoire
Tropical Medicine
Cerebrospinal Fluid
Zambia
Leishmaniasis
Flocculation Tests
Nitroimidazoles
Disease Vectors
Central Nervous System Parasitic Infections
Africa
Livestock
Gabon
Chad
Endemic Diseases
Parasitic Diseases
Protozoan Infections
Guinea
Chancre
Amidines
Parasitemia
Blood
Meningoencephalitis
Disease Reservoirs
Cattle Diseases
Cattle
Tanzania
Kenya
Central Nervous System Diseases
Drug Evaluation, Preclinical
Communicable Diseases, Emerging
DNA, Ribosomal Spacer
A cardiomyocyte mannose receptor system is involved in Trypanosoma cruzi invasion and is down-modulated after infection. (1/251)
Mannosyl binding sites were detected "in vitro" on cardiomyocytes (CM) surface using horseradish peroxidase (HRP) as the ligand. Binding assays revealed a specific recognition system, which was time- and concentration-dependent. The binding required physiological pH and was inhibited by EDTA and trypsin treatments. HRP binding was reduced by pre-incubations with low concentrations of D-mannose. Ultrastructural analysis of the endocytic process was followed using HRP coupled to colloidal gold particles (HRP-Au). The tracer was found within caveolae characterizing early steps of the receptor-mediated endocytosis. The addition of 10 mM D-mannose to the interaction medium blocked Trypanosoma cruzi uptake by CM. The labeling of CM with a subsaturating concentration of HRP-Au before their infection showed, by ultrastructural studies, that its association with trypomastigote forms occurred frequently near to HRP-gold particles that could also be seen to comprise the parasitophorous vacuole. After infection of CM with T. cruzi, a considerable reduction on HRP binding was noticed. Binding was almost completely restored by treating the infected cultures with the trypanocidal drug Nifurtimox. Our "in vitro" findings suggest that cardiomyocyte's mannose receptors localized at the sarcolemma mediates T. cruzi recognition and can be down-modulated by parasite infection. (+info)Evaluation of antigen detection and antibody detection tests for Trypanosoma evansi infections of buffaloes in Indonesia. (2/251)
Two Ag-ELISAs, an IgG-specific antibody detection ELISA (IgG ELISA) and a card agglutination test (CATT) for the detection of Trypanasoma evansi infections in buffaloes in Indonesia, were compared. Diagnostic sensitivity estimates were obtained by testing sera from 139 Indonesian buffaloes which had been found to be infected by parasitological tests. Diagnostic specificity was estimated by testing sera from 263 buffaloes living in Australia. Response-operating characteristic curves were constructed, and optimal ELISA cut-off values, which minimized the number of false-negative and false-positive results, were chosen. The IgG ELISA had the highest sensitivity (89%) and the CATT had the highest specificity (100%). There was a significant difference between the sensitivities (71 and 81%), but not between the specificities (75 and 78%), of the two Ag-ELISAs. The four tests were further compared by calculation of post-test probabilities of infection for positive and negative test results using a range of prevalence values, and likelihood ratios. The results suggested that the CATT was the best test to 'rule-in' infection (i.e. the highest probability of infection in test-positive animals) and the IgG ELISA was the best test to 'rule-out' infection (i.e. the lowest probability of infection in test-negative animals). (+info)Characterization of a vacuolar pyrophosphatase in Trypanosoma brucei and its localization to acidocalcisomes. (3/251)
Inorganic pyrophosphate promoted the acidification of an intracellular compartment in permeabilized procyclic trypomastigotes of Trypanosoma brucei, as measured by acridine orange uptake. The proton gradient generated by pyrophosphate was collapsed by addition of nigericin or NH(4)Cl. Pyrophosphate-driven proton translocation was stimulated by potassium ions and inhibited by KF, by the pyrophosphate analogs imidodiphosphate and aminomethylenediphosphonate (AMDP), and by the thiol reagent p-hydroxymercuribenzoate at concentrations similar to those that inhibit the plant vacuolar H(+)-pyrophosphatase (PPase). The proton translocation activity had a pH optimum around 7.5 and was partially inhibited by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (10 microM) and unaffected by bafilomycin A(1) (40 nM), concanamycin A (5 nM), sodium o-vanadate (500 microM), oligomycin (1 microM), N-ethylmaleimide (100 microM), and KNO(3). AMDP-sensitive pyrophosphate hydrolysis was detected in both procyclic and bloodstream trypomastigotes. Measurements of acridine orange uptake in permeabilized procyclic trypomastigotes in the presence of different substrates and inhibitors suggested the presence of H(+)-ATPase, H(+)-PPase, and (ADP-dependent) H(+)/Na(+) antiport activity in the same compartment. Separation of bloodstream and procyclic trypomastigote extracts on Percoll gradients yielded fractions that contained H(+)-PPase (both stages) and H(+)/Na(+) exchanger (procyclics) activities but lacked markers for mitochondria, glycosomes, and lysosomes. The organelles in these fractions were identified by electron microscopy and X-ray microanalysis as acidocalcisomes (electron-dense vacuoles). These results provide further evidence for the unique nature of acidocalcisomes in comparison with other, previously described, organelles. (+info)Metalloproteases in Trypanosoma rangeli-infected Rhodnius prolixus. (4/251)
Protease activities in the haemolymph and fat body in a bloodsucking insect, Rhodnius prolixus, infected with Trypanosoma rangeli, were investigated. After SDS-polyacrylamide gel electrophoresis containing gelatin as substrate, analysis of zymograms performed on samples of different tissues of controls and insects inoculated or orally infected with short or long epimastigotes of T. rangeli, demonstrated distinct patterns of protease activities: (i) proteases were detected in the haemolymph of insects which were fed on, or inoculated with, short epimastigotes of T. rangeli (39 kDa and 33 kDa, respectively), but they were not observed in the fat body taken from these insects; (ii) protease was also presented in the fat bodies derived from naive insects or controls inoculated with sterile phosphate-saline buffer (49 kDa), but it was not detected in the haemolymph of these insects; (iii) no protease activity was observed in both haemolymph and fat bodies taken from insects inoculated with, or fed on, long epimastigotes of T. rangeli. Furthermore, in short epimastigotes of T. rangeli extracts, three bands of the protease activities with apparent molecular weights of 297, 198 and 95 kDa were detected while long epimastigotes preparation presented only two bands of protease activities with molecular weights of 297 and 198 kDa. The proteases from the insect infected with T. rangeli and controls belong to the class of either metalloproteases or metal-activated enzymes since they are inhibited by 1,10-phenanthroline. The significance of these proteases in the insects infected with short epimastigotes of T. rangeli is discussed in relation to the success of the establishment of infection of these parasites in its vector, R. prolixus. (+info)Procedurally similar competitive immunoassay systems for the serodiagnosis of Babesia equi, Babesia caballi, Trypanosoma equiperdum, and Burkholderia mallei infection in horses. (5/251)
Procedurally similar competitive enzyme-linked immunoassay (cELISA) methods were developed for the serodiagnosis of Babesia equi and Babesia caballi (piroplasmosis), Trypanosoma equiperdum (dourine), and Burkholderia mallei (glanders) infections in horses. Apparent test specificities for the B. equi, B. caballi, T. equiperdum, and B. mallei cELISAs were 99.2%, 99.5%, 98.9%, and 98.9%, respectively. Concordances and kappa values between the complement fixation (CF) and the cELISA procedures for the serodiagnosis of B. equi, B. caballi, T. equiperdum, and B. mallei infections in experimentally exposed horses were 76% and 0.55, 89% and 0.78, 97% and 0.95, and 70% and 0.44, respectively. The cELISA method may be a technically more reproducible, objective, and convenient approach for piroplasmosis, dourine, and glanders serodiagnosis in qualifying animals for international movement and disease eradication programs than the CF systems currently in use. Use of the cELISA method also obviated the problems associated with testing hemolyzed or anticomplementary sera. (+info)The occurrence of Trypanosoma evansi in buffaloes in Indonesia, estimated using various diagnostic tests. (6/251)
The prevalence and incidence of Trypanosoma evansi infections in village buffaloes in Central Java were estimated using parasitological tests, two antigen-detection ELISAs (2G6 Ag-ELISA and Tr7 Ag-ELISA), an antibody-detection ELISA (IgG ELISA) and a card agglutination test (CATT). Of 2387 village buffaloes tested in five districts, 4 % (95 % confidence interval [CI]: 3 %, 5 %) were positive with the microhaematocrit test (MHCT), 58 % (95 % CI: 56 %, 60 %) were positive with the 2G6 Ag-ELISA and 70 % (95 % CI: 68 %, 72 %) were positive with the Tr7 Ag-ELISA. An increasing prevalence with age was found and the proportion of positive buffaloes was highest in the over 84 months-old age-group (68 %) with the 2G6 Ag-ELISA and in the 37-60 months-old age-group (78 %) with the Tr7 Ag-ELISA. Parasitaemic buffaloes were found in more than half of the villages visited. Corrected village-specific prevalence values obtained with the two Ag-ELISAs ranged from 0% to over 100%, and prevalence differed significantly (P < or = 0.0001) between villages in four of the five districts. Overall, 10% of buffaloes tested in markets were found to be parasitaemic and 39, 56 and 47 % were found positive with the 2G6 Ag-ELISA, IgG ELISA and CATT, respectively. Incidence rates varied according to the test used and ranged from 0.22 (95 % CI: 0.09, 0.44) to 0.44 (95 % CI: 0.24, 0.76), per animal-year at risk, in two villages. The results highlight the importance of using validated diagnostic tests to obtain accurate estimates of prevalence and incidence. These parameters are needed, for example in mathematical models, for the development and evaluation of different control strategies for T. evansi infections in buffaloes. (+info)Trypanosomes of non-human primates from the National Centre of Primates, Ananindeua, State of Para, brazil. (7/251)
Trypanosome infections were sought in 46 non-human primates captured principally in Amazonian Brazil. Twenty-two (47.8%) were infected with four Trypanosoma species: T. cruzi, T. minasense, T. devei and T. rangeli. These preliminary results confirmed the high prevalence and diversity of natural infections with trypanosomes in primates from Brazilian Amazon and were the first formal record of simian infections with trypanosomes in the State of Acre. The presence of T. cruzi-like and T. rangeli-like parasites are recorded in four new hosts. (+info)Hypotension in rabbits infected with Trypanosoma brucei. (8/251)
1 Blood pressures and heart rates of 12 anaesthetized rabbits chronically infected with T.brucei were measured (average infection time 39 days (range 25-67). The systolic BP was 31.4 +/- 5.7 mmHg, the diastolic BP 25.0 +/- 7.2 mmHg, and the heart rate 120.5 +/- 24.2 beats/minute. Two rabbits were already hypotensive 10 days after infection. In 12 anaesthetized control rabbits, the systolic BP was 66.2 +/- 7.3 mmHg (mean +/- s.e.), the diastolic BP 60.2 +/- 7.3 mmHg, and the heart rate 116.3 +/- 15.9 beats/minute. 2 The intravenous injection of 3 X 10(8) disintegrated trypanosomes into infected rabbits lowered the blood pressure by 41.4 +/- 22.0%. Pretreatment of two rabbits with aprotinin prior to administration of parasites prevented the fall in blood pressure. 3 Injection of 3 X 10(8) live trypanosomes complexed with hyperimmune sera produced a fall of 68.3 +/- 38.4% in the systolic BP of normal rabbits. Disintegrated or live trypanosomes, or hyperimmune sera alone had no effect. Pretreatment of animals with aprotinin prior to administration of the immune complex abolished the fall in BP. 4 The results suggest that the profound hypotension in chronic trypanosomiasis is caused by complex formation of trypanosomes with antibody. Since it can be prevented by pretreatment with aprotinin, it is likely that activation of plasma kallikrein with a subsequent release of plasma kinins contributes to this effect. (+info)African trypanosomiasis, also known as sleeping sickness, is a vector-borne parasitic disease caused by the protozoan Trypanosoma brucei. It is transmitted to humans through the bite of an infected tsetse fly (Glossina spp.). The disease has two stages: an early hemolymphatic stage characterized by fever, swollen lymph nodes, and skin rashes; and a late neurological stage characterized by sleep disturbances, personality changes, and motor abnormalities. If left untreated, it can be fatal. The disease is endemic in sub-Saharan Africa, where an estimated 65 million people are at risk of infection.
Trypanosomiasis is a parasitic disease caused by various species of the protozoan genus Trypanosoma. It is transmitted through the bite of an infected tsetse fly (in African trypanosomiasis or sleeping sickness) or reduviid bug (in American trypanosomiasis or Chagas disease). The parasites enter the bloodstream and lymphatic system, causing symptoms such as fever, swollen lymph nodes, skin lesions, and muscle pain. Untreated, it can lead to severe neurological complications and death in both forms of the disease. Prevention measures include avoiding insect bites, using insect repellents, and sleeping under insecticide-treated bed nets.
Bovine trypanosomiasis, also known as Nagana, is a parasitic disease that affects cattle and other animals. It is caused by various species of the protozoan parasite Trypanosoma, which are transmitted through the bite of tsetse flies (Glossina spp.).
The disease is characterized by fever, anemia, weight loss, decreased milk production, abortion in pregnant animals, and eventually death if left untreated. The parasites invade the bloodstream and lymphatic system, causing damage to various organs and tissues.
Bovine trypanosomiasis is a major constraint to livestock production in sub-Saharan Africa, where it affects millions of animals and causes significant economic losses to farmers and pastoralists. Control measures include the use of trypanocidal drugs, insecticide-treated cattle, and the reduction or elimination of tsetse fly populations through various methods such as trapping and habitat modification.
Trypanosoma brucei gambiense is a species of protozoan flagellate parasite that causes Human African Trypanosomiasis, also known as sleeping sickness. It is transmitted to humans through the bite of an infected tsetse fly (Glossina spp.). The parasite multiplies in various body fluids, including blood and cerebrospinal fluid, leading to a range of symptoms such as fever, headache, joint pain, and eventually severe neurological disorders if left untreated. T. b. gambiense is responsible for the majority of reported cases in West and Central Africa and is considered to be an anthroponosis, meaning it primarily infects humans.
Melarsoprol is an arsenic-based medication that is primarily used to treat the later stages of African trypanosomiasis, also known as sleeping sickness. It works by inhibiting the enzyme involved in energy metabolism of the parasite causing the disease, leading to its death. However, melarsoprol has a significant risk of serious side effects, including encephalopathy, which can be fatal. Therefore, it is typically used as a last resort when other treatments have failed or are not available. It is administered by intravenous injection in a hospital setting under close medical supervision.
Trypanocidal agents are a type of medication specifically used for the treatment and prevention of trypanosomiasis, which is a group of diseases caused by various species of protozoan parasites belonging to the genus Trypanosoma. These agents work by killing or inhibiting the growth of the parasites in the human body.
There are two main types of human trypanosomiasis: African trypanosomiasis, also known as sleeping sickness, which is caused by Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense; and American trypanosomiasis, also known as Chagas disease, which is caused by Trypanosoma cruzi.
Trypanocidal agents can be divided into two categories:
1. Drugs used to treat African trypanosomiasis: These include pentamidine, suramin, melarsoprol, and eflornithine. Pentamidine and suramin are used for the early stages of the disease, while melarsoprol and eflornithine are used for the later stages.
2. Drugs used to treat American trypanosomiasis: The main drug used for Chagas disease is benznidazole, which is effective in killing the parasites during the acute phase of the infection. Another drug, nifurtimox, can also be used, although it has more side effects than benznidazole.
It's important to note that trypanocidal agents have limited availability and are often associated with significant toxicity, making their use challenging in some settings. Therefore, prevention measures such as avoiding insect vectors and using vector control methods remain crucial in controlling the spread of these diseases.
Trypanosoma brucei rhodesiense is a species of protozoan parasite that causes African trypanosomiasis, also known as sleeping sickness, in humans. It is transmitted through the bite of an infected tsetse fly and is endemic to certain regions of East and Southern Africa.
The life cycle of T. b. rhodesiense involves two hosts: the tsetse fly and a mammalian host (such as a human). In the tsetse fly, the parasite undergoes development and multiplication in the midgut, then migrates to the salivary glands where it transforms into the metacyclic trypomastigote stage. When the infected tsetse fly bites a mammalian host, the metacyclic trypomastigotes are injected into the skin and enter the lymphatic system and bloodstream, where they multiply by binary fission as bloodstream trypomastigotes.
The symptoms of African trypanosomiasis caused by T. b. rhodesiense include fever, headache, joint pain, and itching, which may progress to more severe symptoms such as sleep disturbances, confusion, and neurological disorders if left untreated. The disease can be fatal if not diagnosed and treated promptly.
It is important to note that T. b. rhodesiense is distinct from another subspecies of Trypanosoma brucei called T. b. gambiense, which causes a different form of African trypanosomiasis that is endemic to West and Central Africa.
Trypanosoma brucei brucei is a species of protozoan flagellate parasite that causes African trypanosomiasis, also known as sleeping sickness in humans and Nagana in animals. This parasite is transmitted through the bite of an infected tsetse fly (Glossina spp.). The life cycle of T. b. brucei involves two main stages: the insect-dwelling procyclic trypomastigote stage and the mammalian-dwelling bloodstream trypomastigote stage.
The distinguishing feature of T. b. brucei is its ability to change its surface coat, which helps it evade the host's immune system. This allows the parasite to establish a long-term infection in the mammalian host. However, T. b. brucei is not infectious to humans; instead, two other subspecies, Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, are responsible for human African trypanosomiasis.
In summary, Trypanosoma brucei brucei is a non-human-infective subspecies of the parasite that causes African trypanosomiasis in animals and serves as an essential model organism for understanding the biology and pathogenesis of related human-infective trypanosomes.
Trypanosoma is a genus of flagellated protozoan parasites belonging to the family Trypanosomatidae. These microscopic single-celled organisms are known to cause various tropical diseases in humans and animals, including Chagas disease (caused by Trypanosoma cruzi) and African sleeping sickness (caused by Trypanosoma brucei).
The life cycle of Trypanosoma involves alternating between an insect vector (like a tsetse fly or kissing bug) and a mammalian host. The parasites undergo complex morphological changes as they move through the different hosts and developmental stages, often exhibiting distinct forms in the insect vector compared to the mammalian host.
Trypanosoma species have an undulating membrane and a single flagellum that helps them move through their environment. They can be transmitted through various routes, including insect vectors, contaminated food or water, or congenital transmission from mother to offspring. The diseases caused by these parasites can lead to severe health complications and may even be fatal if left untreated.
Tsetse flies are not a medical condition but rather insects that can transmit diseases. Here is their medical relevance:
Tsetse flies (Glossina spp.) are large, biting flies found primarily in tropical Africa. They are vectors for African trypanosomiasis, also known as sleeping sickness in humans and Nagana in animals. The fly ingests the parasite when it takes a blood meal from an infected host, then transmits the disease to another host through its saliva during subsequent feedings. This makes tsetse flies medically relevant due to their role in spreading these diseases.
Trypanosoma congolense is a species of protozoan parasite that belongs to the genus Trypanosoma. It is the primary causative agent of African animal trypanosomiasis (AAT), also known as Nagana, which affects both wild and domestic animals in sub-Saharan Africa.
The life cycle of T. congolense involves two main hosts: the tsetse fly (Glossina spp.) and a mammalian host, such as cattle, sheep, goats, or wild animals. The parasite is transmitted to the mammalian host through the bite of an infected tsetse fly. Once inside the host's body, T. congolense multiplies in various bodily fluids, including blood, lymph, and cerebrospinal fluid, causing a range of symptoms such as fever, anemia, weight loss, and weakness.
In severe cases, AAT can lead to death, particularly in young or debilitated animals. The disease has significant economic impacts on agriculture and livestock production in affected regions, making it a major public health concern.
Trypanosoma vivax is a species of protozoan parasite that causes the disease surra in horses, mules, and donkeys, as well as other animals such as camels, dogs, and cats. It belongs to the family Trypanosomatidae and the order Kinetoplastida.
The parasite is transmitted through the bite of infected tsetse flies (Glossina spp.) and occurs in parts of Africa and Asia. The parasites multiply in the bloodstream and lymphatic system of the host, causing symptoms such as fever, anemia, weakness, and edema.
In advanced stages, surra can lead to severe neurological signs, coma, and death if left untreated. Diagnosis is typically made through microscopic examination of blood or tissue samples, and treatment involves the use of drugs such as diminazene accurate or suramin. Prevention measures include avoiding exposure to tsetse flies and using insect repellents or protective clothing.
I'm not aware of any medical definitions associated with the term "Angola." Angola is a country located in Southern Africa, known officially as the Republic of Angola. It does not have any specific relevance to medical terminology or healthcare. If you have more context or information about why you are looking for a medical definition of Angola, I may be able to provide a more helpful response.
The Democratic Republic of the Congo (DRC) is a country located in Central Africa. It is named after the Congo River, which flows through the country. The DRC is the second-largest country in Africa by area and the eleventh-largest in the world. It is home to a diverse population of more than 80 million people, making it one of the most populous countries on the continent.
The DRC is a democratic republic, which means that it is a form of government in which the people have the power to choose their leaders through free and fair elections. The country has a presidential system of government, in which the president serves as both the head of state and the head of government. The current president of the DRC is Félix Tshisekedi, who took office in January 2019.
The DRC is a federal republic, meaning that it is divided into several provinces, each with its own elected government. The country has a total of 26 provinces, which are further divided into districts and sectors.
The DRC is a member of various international organizations, including the United Nations, the African Union, and the Southern African Development Community. It is also a party to several international treaties and agreements, such as the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) and the Paris Agreement on climate change.
The DRC has a mixed economy, with both private and public sectors playing important roles. The country is rich in natural resources, including minerals such as copper, diamonds, gold, and tin. It also has large areas of fertile land that are suitable for agriculture. However, the DRC faces significant challenges, including poverty, corruption, and conflict. Despite these challenges, the country has made progress in recent years in terms of economic growth and development.
Pentamidine is an antimicrobial drug that is primarily used to treat and prevent certain types of pneumonia caused by the parasitic organisms Pneumocystis jirovecii (formerly known as P. carinii) and Leishmania donovani. It can also be used for the treatment of some fungal infections caused by Histoplasma capsulatum and Cryptococcus neoformans.
Pentamidine works by interfering with the DNA replication and protein synthesis of these microorganisms, which ultimately leads to their death. It is available as an injection or inhaled powder for medical use. Common side effects of pentamidine include nausea, vomiting, diarrhea, abdominal pain, and changes in blood sugar levels. More serious side effects can include kidney damage, hearing loss, and heart rhythm disturbances.
It is important to note that the use of pentamidine should be under the supervision of a healthcare professional due to its potential for serious side effects and drug interactions.
I'm not aware of any medical definitions associated with the term "Congo." The term "Congo" is most commonly used to refer to:
1. The Congo River, which is the second longest river in Africa, flowing through the Democratic Republic of the Congo and the Republic of the Congo.
2. The two countries located in Central Africa that share the name "Congo": the Democratic Republic of the Congo (formerly known as Zaire) and the Republic of the Congo (formerly known as French Congo or Middle Congo).
3. In historical contexts, "Congo" may also refer to the Congo Free State (1885-1908), a private colony of King Leopold II of Belgium, which later became the Belgian Congo (1908-1960) and then Zaire (1971-1997).
If you are looking for medical information or definitions related to tropical diseases, healthcare in Africa, or similar topics, I would recommend using more specific terms.
Central nervous system (CNS) protozoal infections refer to diseases caused by protozoa that invade and infect the brain and spinal cord. These infections can lead to serious neurological symptoms and complications.
There are several types of protozoa that can cause CNS infections, including:
1. Toxoplasma gondii: This parasite is commonly found in cats and can be transmitted to humans through contact with infected cat feces or consumption of undercooked meat. In people with weakened immune systems, T. gondii can cause severe CNS symptoms such as seizures, confusion, and coma.
2. Naegleria fowleri: Also known as the "brain-eating amoeba," N. fowleri is a free-living protozoan found in warm freshwater environments. When people swim or dive in infected water, the amoeba can enter the body through the nose and travel to the brain, causing primary amoebic meningoencephalitis (PAM), a rare but often fatal CNS infection.
3. Acanthamoeba: Like N. fowleri, Acanthamoeba is a free-living protozoan found in freshwater and soil. It can cause a range of CNS infections, including granulomatous amoebic encephalitis (GAE), which typically affects people with weakened immune systems.
4. Trypanosoma brucei: This parasite is transmitted through the bite of infected tsetse flies and causes African sleeping sickness, a CNS infection that can lead to coma and death if left untreated.
5. Plasmodium falciparum: While not strictly a protozoan, P. falciparum is a parasite that causes malaria, a mosquito-borne disease that can cause severe CNS symptoms such as seizures, coma, and cerebral malaria.
Treatment for CNS protozoal infections depends on the specific type of infection and may include antiprotozoal medications, antibiotics, or supportive care to manage symptoms. Prevention measures include avoiding contact with infected animals or insects, practicing good hygiene, and using appropriate protective measures such as insect repellent or bed nets in areas where these infections are common.
Nifurtimox is an antiprotozoal medication used in the treatment of acute and chronic stages of American trypanosomiasis (Chagas disease) caused by Trypanosoma cruzi. It works by inhibiting the parasite's energy metabolism, ultimately leading to its death. Nifurtimox is often given orally in the form of tablets and its use is typically accompanied by close medical supervision due to potential side effects such as anorexia, nausea, vomiting, and neurological symptoms.
Eflornithine is a antiprotozoal medication, which is used to treat sleeping sickness (human African trypanosomiasis) caused by Trypanosoma brucei gambiense in adults and children. It works by inhibiting the enzyme ornithine decarboxylase, which is needed for the growth of the parasite. By doing so, it helps to control the infection and prevent further complications.
Eflornithine is also used as a topical cream to slow down excessive hair growth in women due to a condition called hirsutism. It works by interfering with the growth of hair follicles.
It's important to note that Eflornithine should be used under the supervision of a healthcare professional, and it may have side effects or interactions with other medications.
Antiprotozoal agents are a type of medication used to treat protozoal infections, which are infections caused by microscopic single-celled organisms called protozoa. These agents work by either killing the protozoa or inhibiting their growth and reproduction. They can be administered through various routes, including oral, topical, and intravenous, depending on the type of infection and the severity of the illness.
Examples of antiprotozoal agents include:
* Metronidazole, tinidazole, and nitazoxanide for treating infections caused by Giardia lamblia and Entamoeba histolytica.
* Atovaquone, clindamycin, and pyrimethamine-sulfadoxine for treating malaria caused by Plasmodium falciparum or other Plasmodium species.
* Pentamidine and suramin for treating African trypanosomiasis (sleeping sickness) caused by Trypanosoma brucei gambiense or T. b. rhodesiense.
* Nitroimidazoles, such as benznidazole and nifurtimox, for treating Chagas disease caused by Trypanosoma cruzi.
* Sodium stibogluconate and paromomycin for treating leishmaniasis caused by Leishmania species.
Antiprotozoal agents can have side effects, ranging from mild to severe, depending on the drug and the individual patient's response. It is essential to follow the prescribing physician's instructions carefully when taking these medications and report any adverse reactions promptly.
I'm sorry for any confusion, but "Sudan" is not a medical term. It is a country located in Northeast Africa, known as the Sudan or Sudan proper, and the southern region that seceded to become South Sudan in 2011. If you have any medical terms you would like me to define, please let me know!
'Insect control' is not a term typically used in medical definitions. However, it generally refers to the methods and practices used to manage or reduce the population of insects that can be harmful or disruptive to human health, food supply, or property. This can include various strategies such as chemical pesticides, biological control agents, habitat modification, and other integrated pest management techniques.
In medical terms, 'vector control' is a more relevant concept, which refers to the specific practices used to reduce or prevent the transmission of infectious diseases by insects and other arthropods that act as disease vectors (such as mosquitoes, ticks, and fleas). Vector control measures may include the use of insecticides, larvicides, biological control agents, environmental management, personal protection methods, and other integrated vector management strategies.
Chagas disease, also known as American trypanosomiasis, is a tropical parasitic disease caused by the protozoan *Trypanosoma cruzi*. It is primarily transmitted to humans through the feces of triatomine bugs (also called "kissing bugs"), which defecate on the skin of people while they are sleeping. The disease can also be spread through contaminated food or drink, during blood transfusions, from mother to baby during pregnancy or childbirth, and through organ transplantation.
The acute phase of Chagas disease can cause symptoms such as fever, fatigue, body aches, headache, rash, loss of appetite, diarrhea, and vomiting. However, many people do not experience any symptoms during the acute phase. After several weeks or months, most people enter the chronic phase of the disease, which can last for decades or even a lifetime. During this phase, many people do not have any symptoms, but about 20-30% of infected individuals will develop serious cardiac or digestive complications, such as heart failure, arrhythmias, or difficulty swallowing.
Chagas disease is primarily found in Latin America, where it is estimated that around 6-7 million people are infected with the parasite. However, due to increased travel and migration, cases of Chagas disease have been reported in other parts of the world, including North America, Europe, and Asia. There is no vaccine for Chagas disease, but medications are available to treat the infection during the acute phase and to manage symptoms during the chronic phase.
The Central African Republic (CAR) is a country located in the central region of Africa. It is not a medical term, but a geographical and political designation for a nation that has its own government, healthcare system, and public health challenges.
The CAR faces significant health issues, including a high burden of infectious diseases such as malaria, HIV/AIDS, tuberculosis, and neglected tropical diseases. Access to healthcare services is limited, particularly in rural areas, and the country has one of the lowest life expectancies in the world. Political instability and conflict have further exacerbated the health challenges in the CAR, leading to displacement, malnutrition, and reduced access to healthcare for many of its citizens.
Trypanosoma cruzi is a protozoan parasite that causes Chagas disease, also known as American trypanosomiasis. It's transmitted to humans and other mammals through the feces of triatomine bugs, often called "kissing bugs." The parasite can also be spread through contaminated food, drink, or from mother to baby during pregnancy or birth.
The life cycle of Trypanosoma cruzi involves two main forms: the infective metacyclic trypomastigote that is found in the bug's feces and the replicative intracellular amastigote that resides within host cells. The metacyclic trypomastigotes enter the host through mucous membranes or skin lesions, where they invade various types of cells and differentiate into amastigotes. These amastigotes multiply by binary fission and then differentiate back into trypomastigotes, which are released into the bloodstream when the host cell ruptures. The circulating trypomastigotes can then infect other cells or be taken up by another triatomine bug during a blood meal, continuing the life cycle.
Clinical manifestations of Chagas disease range from an acute phase with non-specific symptoms like fever, swelling, and fatigue to a chronic phase characterized by cardiac and gastrointestinal complications, which can develop decades after the initial infection. Early detection and treatment of Chagas disease are crucial for preventing long-term health consequences.
Suramin is a medication that has been used for the treatment of African sleeping sickness, which is caused by trypanosomes. It works as a reverse-specific protein kinase CK inhibitor and also blocks the attachment of the parasite to the host cells. Suramin is not absorbed well from the gastrointestinal tract and is administered intravenously.
It should be noted that Suramin is an experimental treatment for other conditions such as cancer, neurodegenerative diseases, viral infections and autoimmune diseases, but it's still under investigation and has not been approved by FDA for those uses.
Diminazene is an antiparasitic drug, primarily used in veterinary medicine to treat and prevent infections caused by trypanosomes, which are protozoan parasites that can affect both animals and humans. The drug works by inhibiting the protein synthesis of the parasite, leading to its death.
In human medicine, diminazene is used as an alternative treatment for acute African trypanosomiasis (sleeping sickness) caused by Trypanosoma brucei gambiense in areas where other treatments are not available or have failed. It is usually given by intramuscular injection and is often used in combination with suramin.
It's important to note that the use of diminazene in human medicine is limited due to its potential toxicity, and it should only be administered under the supervision of a healthcare professional.
Benzamidines are a group of organic compounds that contain a benzene ring linked to an amidine functional group. They are commonly used as antimicrobial agents, particularly in the treatment of various gram-negative bacterial infections. Benzamidines work by inhibiting the enzyme bacterial dehydrogenases, which are essential for the bacteria's survival.
Some examples of benzamidine derivatives include:
* Tempanamine hydrochloride (Tembaglanil): used to treat urinary tract infections caused by susceptible strains of Escherichia coli and Klebsiella pneumoniae.
* Chlorhexidine: a broad-spectrum antimicrobial agent used as a disinfectant and preservative in various medical and dental applications.
* Prothiobenzamide: an anti-inflammatory and analgesic drug used to treat gout and rheumatoid arthritis.
It is important to note that benzamidines have a narrow therapeutic index, which means that the difference between an effective dose and a toxic dose is small. Therefore, they should be used with caution and under the supervision of a healthcare professional.
Neglected Tropical Diseases (NTDs) are a group of infectious diseases that primarily affect people living in poverty, in tropical and subtropical areas. These diseases are called "neglected" because they have been largely ignored by medical research and drug development, as well as by global health agencies and pharmaceutical companies.
The World Health Organization (WHO) has identified 20 diseases as NTDs, including:
1. Buruli ulcer
2. Chagas disease
3. Dengue and chikungunya
4. Dracunculiasis (guinea-worm disease)
5. Echinococcosis
6. Endemic treponematoses
7. Foodborne trematodiases
8. Human African trypanosomiasis (sleeping sickness)
9. Leishmaniasis
10. Leprosy (Hansen's disease)
11. Lymphatic filariasis
12. Onchocerciasis (river blindness)
13. Rabies
14. Schistosomiasis
15. Soil-transmitted helminthiases
16. Snakebite envenoming
17. Taeniasis/Cysticercosis
18. Trachoma
19. Mycetoma, chromoblastomycosis and other deep mycoses
20. Yaws (Endemic treponematoses)
These diseases can lead to severe disfigurement, disability, and even death if left untreated. They affect more than 1 billion people worldwide, mainly in low-income countries in Africa, Asia, and the Americas. NTDs also have significant social and economic impacts, contributing to poverty, stigma, discrimination, and exclusion.
Efforts are underway to raise awareness and increase funding for research, prevention, and treatment of NTDs. The WHO has set targets for controlling or eliminating several NTDs by 2030, including dracunculiasis, lymphatic filariasis, onchocerciasis, trachoma, and human African trypanosomiasis.
I'm sorry for any confusion, but "Uganda" is not a medical term or concept. It is the name of a country located in East Africa, known officially as the Republic of Uganda. If you have any questions about medical terms or concepts, I would be happy to help with those!
Central Africa is a geographical region that broadly includes the countries that lie near the equator and are found in the interior of the African continent. The United Nations defines Central Africa as consisting of the following countries: Angola, Burundi, Cameroon, Central African Republic, Chad, Democratic Republic of the Congo, Republic of the Congo, Equatorial Guinea, Gabon, Rwanda, and Sao Tome and Principe.
The region is characterized by diverse cultures, languages, and landscapes, ranging from dense rainforests to vast savannas. Central Africa is home to many important rivers, including the Congo River, which is the second longest river in Africa and the deepest river in the world. The region also contains numerous national parks and wildlife reserves that protect a diverse array of plant and animal species, including several endangered species such as mountain gorillas, chimpanzees, and forest elephants.
Central Africa faces many challenges, including political instability, poverty, and environmental degradation. The region has been plagued by conflicts and civil wars, which have resulted in significant loss of life, displacement of people, and destruction of infrastructure. Climate change and deforestation are also major concerns, as they threaten the region's biodiversity and contribute to global warming.
In terms of healthcare, Central Africa faces many challenges, including a high burden of infectious diseases such as HIV/AIDS, malaria, tuberculosis, and Ebola. Access to healthcare is limited in many areas, particularly in rural communities, and there is a shortage of healthcare workers and medical facilities. In addition, the region has been affected by conflicts and humanitarian crises, which have further strained healthcare systems and made it difficult to provide adequate care to those in need.
Parasitic sensitivity tests, also known as parasite drug susceptibility tests, refer to laboratory methods used to determine the effectiveness of specific antiparasitic medications against a particular parasitic infection. These tests help healthcare providers identify which drugs are most likely to be effective in treating an individual's infection and which ones should be avoided due to resistance or increased risk of side effects.
There are several types of parasitic sensitivity tests, including:
1. In vitro susceptibility testing: This involves culturing the parasite in a laboratory setting and exposing it to different concentrations of antiparasitic drugs. The growth or survival of the parasite is then observed and compared to a control group that was not exposed to the drug. This helps identify the minimum inhibitory concentration (MIC) of the drug, which is the lowest concentration required to prevent the growth of the parasite.
2. Molecular testing: This involves analyzing the genetic material of the parasite to detect specific mutations or gene variations that are associated with resistance to certain antiparasitic drugs. This type of testing can be performed using a variety of methods, including polymerase chain reaction (PCR) and DNA sequencing.
3. Phenotypic testing: This involves observing the effects of antiparasitic drugs on the growth or survival of the parasite in a laboratory setting. For example, a parasite may be grown in a culture medium and then exposed to different concentrations of a drug. The growth of the parasite is then monitored over time to determine the drug's effectiveness.
Parasitic sensitivity tests are important for guiding the treatment of many parasitic infections, including malaria, tuberculosis, and leishmaniasis. These tests can help healthcare providers choose the most effective antiparasitic drugs for their patients, reduce the risk of drug resistance, and improve treatment outcomes.
Variants surface glycoproteins (VSGs) in Trypanosoma are a group of molecules found on the surface of the parasitic protozoan that causes African trypanosomiasis, also known as sleeping sickness. These proteins play a crucial role in the survival of the parasite within the host's body by allowing it to evade the host's immune system.
Trypanosoma parasites have a single VSG gene that is actively expressed at any given time, while thousands of other VSG genes remain silent. The expressed VSG protein is located on the surface of the parasite and serves as a target for the host's immune response. However, when the host's immune system produces antibodies against the VSG protein, the parasite undergoes a process called "antigenic variation" where it switches to expressing a different VSG gene, allowing it to evade the immune response.
This continuous switching of VSG genes allows the parasite to avoid clearance by the host's immune system and establish a chronic infection. Understanding the mechanisms of antigenic variation and VSG gene regulation is important for developing new strategies for treating African trypanosomiasis.
Agglutination tests are laboratory diagnostic procedures used to detect the presence of antibodies or antigens in a sample, such as blood or serum. These tests work by observing the clumping (agglutination) of particles, like red blood cells or bacteriophages, coated with specific antigens or antibodies when mixed with a patient's sample.
In an agglutination test, the sample is typically combined with a reagent containing known antigens or antibodies on the surface of particles, such as latex beads, red blood cells, or bacteriophages. If the sample contains the corresponding antibodies or antigens, they will bind to the particles, forming visible clumps or agglutinates. The presence and strength of agglutination are then assessed visually or with automated equipment to determine the presence and quantity of the target antigen or antibody in the sample.
Agglutination tests are widely used in medical diagnostics for various applications, including:
1. Bacterial and viral infections: To identify specific bacterial or viral antigens in a patient's sample, such as group A Streptococcus, Legionella pneumophila, or HIV.
2. Blood typing: To determine the ABO blood group and Rh type of a donor or recipient before a blood transfusion or organ transplantation.
3. Autoimmune diseases: To detect autoantibodies in patients with suspected autoimmune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, or Hashimoto's thyroiditis.
4. Allergies: To identify specific IgE antibodies in a patient's sample to determine allergic reactions to various substances, such as pollen, food, or venom.
5. Drug monitoring: To detect and quantify the presence of drug-induced antibodies, such as those developed in response to penicillin or hydralazine therapy.
Agglutination tests are simple, rapid, and cost-effective diagnostic tools that provide valuable information for clinical decision-making and patient management. However, they may have limitations, including potential cross-reactivity with other antigens, false-positive results due to rheumatoid factors or heterophile antibodies, and false-negative results due to the prozone effect or insufficient sensitivity. Therefore, it is essential to interpret agglutination test results in conjunction with clinical findings and other laboratory data.
Parasitology is a branch of biology that deals with the study of parasites, their life cycles, the relationship between parasites and their hosts, the transmission of parasitic diseases, and the development of methods for their control and elimination. It involves understanding various types of parasites including protozoa, helminths, and arthropods that can infect humans, animals, and plants. Parasitologists also study the evolution, genetics, biochemistry, and ecology of parasites to develop effective strategies for their diagnosis, treatment, and prevention.
Antibodies, protozoan, refer to the immune system's response to an infection caused by a protozoan organism. Protozoa are single-celled microorganisms that can cause various diseases in humans, such as malaria, giardiasis, and toxoplasmosis.
When the body is infected with a protozoan, the immune system responds by producing specific proteins called antibodies. Antibodies are produced by a type of white blood cell called a B-cell, and they recognize and bind to specific antigens on the surface of the protozoan organism.
There are five main types of antibodies: IgA, IgD, IgE, IgG, and IgM. Each type of antibody has a different role in the immune response. For example, IgG is the most common type of antibody and provides long-term immunity to previously encountered pathogens. IgM is the first antibody produced in response to an infection and is important for activating the complement system, which helps to destroy the protozoan organism.
Overall, the production of antibodies against protozoan organisms is a critical part of the immune response and helps to protect the body from further infection.
Insect vectors are insects that transmit disease-causing pathogens (such as viruses, bacteria, parasites) from one host to another. They do this while feeding on the host's blood or tissues. The insects themselves are not infected by the pathogen but act as mechanical carriers that pass it on during their bite. Examples of diseases spread by insect vectors include malaria (transmitted by mosquitoes), Lyme disease (transmitted by ticks), and plague (transmitted by fleas). Proper prevention measures, such as using insect repellent and reducing standing water where mosquitoes breed, can help reduce the risk of contracting these diseases.
To the best of my knowledge, "Côte d'Ivoire" is not a medical term or concept. It is the name of a country, which is officially known as the Republic of Côte d'Ivoire. The country is located in West Africa and is bordered by countries such as Ghana, Mali, Burkina Faso, and Liberia.
Côte d'Ivoire was once a French colony and gained its independence in 1960. The country has a diverse population and a developing economy, with agriculture being a major contributor to its GDP. The capital city of Côte d'Ivoire is Yamoussoukro, while the largest city is Abidjan.
It's important to note that medical terminology and concepts are typically related to anatomy, physiology, diseases, treatments, and other health-related topics. Therefore, it's unlikely that a country name like Côte d'Ivoire would have a direct medical definition or application.
Tropical medicine is a branch of medicine that deals with health problems that are prevalent in or unique to tropical and subtropical regions. These regions are typically characterized by hot and humid climates, and often have distinct ecological systems that can contribute to the spread of infectious diseases.
The field of tropical medicine encompasses a wide range of health issues, including:
1. Infectious diseases: Many tropical diseases are caused by infectious agents such as bacteria, viruses, parasites, and fungi. Some of the most common infectious diseases in the tropics include malaria, dengue fever, yellow fever, chikungunya, Zika virus, leishmaniasis, schistosomiasis, and Chagas disease.
2. Neglected tropical diseases (NTDs): A group of chronic infectious diseases that primarily affect poor and marginalized populations in the tropics. NTDs include diseases such as human African trypanosomiasis (sleeping sickness), leprosy, Buruli ulcer, and dracunculiasis (guinea worm disease).
3. Zoonotic diseases: Diseases that are transmitted between animals and humans, often through insect vectors or contaminated food and water. Examples of zoonotic diseases in the tropics include rabies, leptospirosis, and Rift Valley fever.
4. Environmental health issues: The tropical environment can pose unique health challenges, such as exposure to toxic chemicals, heat stress, and poor air quality. Tropical medicine also addresses these environmental health issues.
5. Travel medicine: As global travel increases, there is a growing need for medical professionals who are knowledgeable about the health risks associated with traveling to tropical destinations. Tropical medicine physicians often provide pre-travel consultations and post-travel evaluations for international travelers.
Overall, tropical medicine is an essential field that addresses the unique health challenges faced by populations living in or traveling to tropical and subtropical regions.
Cerebrospinal fluid (CSF) is a clear, colorless fluid that surrounds and protects the brain and spinal cord. It acts as a shock absorber for the central nervous system and provides nutrients to the brain while removing waste products. CSF is produced by specialized cells called ependymal cells in the choroid plexus of the ventricles (fluid-filled spaces) inside the brain. From there, it circulates through the ventricular system and around the outside of the brain and spinal cord before being absorbed back into the bloodstream. CSF analysis is an important diagnostic tool for various neurological conditions, including infections, inflammation, and cancer.
I'm sorry for any confusion, but "Zambia" is not a medical term. It is the name of a country located in southern Africa, known officially as the Republic of Zambia. If you have any questions related to medical terminology or health-related topics, I would be happy to help with those!
Leishmaniasis is a complex of diseases caused by the protozoan parasites of the Leishmania species, which are transmitted to humans through the bite of infected female phlebotomine sandflies. The disease presents with a variety of clinical manifestations, depending upon the Leishmania species involved and the host's immune response.
There are three main forms of leishmaniasis: cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL), also known as kala-azar. CL typically presents with skin ulcers, while MCL is characterized by the destruction of mucous membranes in the nose, mouth, and throat. VL, the most severe form, affects internal organs such as the spleen, liver, and bone marrow, causing symptoms like fever, weight loss, anemia, and enlarged liver and spleen.
Leishmaniasis is prevalent in many tropical and subtropical regions, including parts of Asia, Africa, South America, and southern Europe. The prevention strategies include using insect repellents, wearing protective clothing, and improving housing conditions to minimize exposure to sandflies. Effective treatment options are available for leishmaniasis, depending on the form and severity of the disease, geographical location, and the Leishmania species involved.
Flocculation tests are diagnostic procedures used in medical laboratories to detect and measure the presence of certain substances, such as proteins or bacteria, in a sample. These tests work by adding a reagent to the sample that causes any targeted substances to clump together (flocculate) and become visible or easily measurable.
For example, in a coagulation or flocculation test for proteinuria (protein in urine), a reagent such as sulfosalicylic acid is added to a urine sample. If proteins are present in the sample, they will react with the reagent and form a white precipitate that can be seen with the naked eye or measured with a spectrophotometer.
Flocculation tests are commonly used in clinical chemistry and microbiology to diagnose various medical conditions, monitor treatment progress, and assess overall health status.
Nitroimidazoles are a class of antibiotic drugs that contain a nitro group (-NO2) attached to an imidazole ring. These medications have both antiprotozoal and antibacterial properties, making them effective against a range of anaerobic organisms, including bacteria and parasites. They work by being reduced within the organism, which leads to the formation of toxic radicals that interfere with DNA function and ultimately kill the microorganism.
Some common examples of nitroimidazoles include:
* Metronidazole: used for treating infections caused by anaerobic bacteria and protozoa, such as bacterial vaginosis, amebiasis, giardiasis, and pseudomembranous colitis.
* Tinidazole: similar to metronidazole, it is used to treat various infections caused by anaerobic bacteria and protozoa, including trichomoniasis, giardiasis, and amebiasis.
* Secnidazole: another medication in this class, used for the treatment of bacterial vaginosis, trichomoniasis, and amebiasis.
Nitroimidazoles are generally well-tolerated, but side effects can include gastrointestinal symptoms like nausea, vomiting, or diarrhea. Rare but serious side effects may include peripheral neuropathy (nerve damage) and central nervous system toxicity, particularly with high doses or long-term use. It is essential to follow the prescribed dosage and duration closely to minimize potential risks while ensuring effective treatment.
A disease vector is a living organism that transmits infectious pathogens from one host to another. These vectors can include mosquitoes, ticks, fleas, and other arthropods that carry viruses, bacteria, parasites, or other disease-causing agents. The vector becomes infected with the pathogen after biting an infected host, and then transmits the infection to another host through its saliva or feces during a subsequent blood meal.
Disease vectors are of particular concern in public health because they can spread diseases rapidly and efficiently, often over large geographic areas. Controlling vector-borne diseases requires a multifaceted approach that includes reducing vector populations, preventing bites, and developing vaccines or treatments for the associated diseases.
Central nervous system (CNS) parasitic infections refer to the invasion and infection of the brain and/or spinal cord by parasites. These infections can cause a range of symptoms depending on the type of parasite, the location of the infection within the CNS, and the severity of the infection.
Parasites that can infect the CNS include protozoa (such as Toxoplasma gondii, Naegleria fowleri, and Plasmodium falciparum), helminths (such as cysticercosis caused by Taenia solium tapeworm larvae), and arthropods (such as ticks that can transmit Lyme disease).
Symptoms of CNS parasitic infections can include headache, fever, seizures, confusion, weakness, numbness, loss of coordination, and changes in behavior or personality. Diagnosis typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT scans), and laboratory tests (such as CSF analysis or PCR).
Treatment for CNS parasitic infections depends on the specific type of parasite involved and may include medications such as antiparasitics, antibiotics, or corticosteroids. In some cases, surgery may be necessary to remove parasites or cysts from the CNS. Prevention measures include avoiding contaminated food and water, practicing good hygiene, using insect repellent, and seeking prompt medical attention for any suspected infectious symptoms.
There doesn't seem to be a specific medical definition for "DNA, protozoan" as it is simply a reference to the DNA found in protozoa. Protozoa are single-celled eukaryotic organisms that can be found in various environments such as soil, water, and the digestive tracts of animals.
Protozoan DNA refers to the genetic material present in these organisms. It is composed of nucleic acids, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), which contain the instructions for the development, growth, and reproduction of the protozoan.
The DNA in protozoa, like in other organisms, is made up of two strands of nucleotides that coil together to form a double helix. The four nucleotide bases that make up protozoan DNA are adenine (A), thymine (T), guanine (G), and cytosine (C). These bases pair with each other to form the rungs of the DNA ladder, with A always pairing with T and G always pairing with C.
The genetic information stored in protozoan DNA is encoded in the sequence of these nucleotide bases. This information is used to synthesize proteins, which are essential for the structure and function of the organism's cells. Protozoan DNA also contains other types of genetic material, such as regulatory sequences that control gene expression and repetitive elements with no known function.
Understanding the DNA of protozoa is important for studying their biology, evolution, and pathogenicity. It can help researchers develop new treatments for protozoan diseases and gain insights into the fundamental principles of genetics and cellular function.
I'm sorry for any confusion, but the term "Africa" actually refers to a continent, not a medical condition or concept. Africa is the second-largest continent in the world, consisting of 54 countries and a wide range of diverse ethnic groups, cultures, languages, and landscapes. It is home to a vast array of wildlife, including many species that are not found anywhere else in the world. If you have any questions about Africa's geography, history, or culture, I would be happy to try to help answer them!
I apologize for any confusion, but "livestock" is not a term that has a medical definition. It is an agricultural term that refers to animals that are kept or raised on a farm or ranch for commercial purposes, such as the production of food, fiber, or labor. Examples of livestock include cattle, sheep, goats, pigs, poultry, and horses. I hope this clarifies any confusion. If you have any questions related to medical terminology, I would be happy to help.
I'm sorry for any confusion, but "Gabon" is not a medical term. It is the name of a country located in Central Africa, known officially as the Gabonese Republic. If you have any questions about medical terminology or health-related topics, I would be happy to help with those!
I'm sorry for any confusion, but "Protozoan Proteins" is not a specific medical or scientific term. Protozoa are single-celled eukaryotic organisms, and proteins are large biological molecules consisting of one or more chains of amino acid residues. Therefore, "Protozoan Proteins" generally refers to the various types of proteins found in protozoa.
However, if you're looking for information about proteins specific to certain protozoan parasites with medical relevance (such as Plasmodium falciparum, which causes malaria), I would be happy to help! Please provide more context or specify the particular protozoan of interest.
I apologize, but "Chad" is not a medical term or condition. It is a given name and also a slang term that has been used in popular culture to refer to an attractive man or a stereotypical fraternity member in some English-speaking countries. If you have any questions about medical terminology, I would be happy to help answer those for you.
An endemic disease is a type of disease that is regularly found among particular people or in a certain population, and is spread easily from person to person. The rate of infection is consistently high in these populations, but it is relatively stable and does not change dramatically over time. Endemic diseases are contrasted with epidemic diseases, which suddenly increase in incidence and spread rapidly through a large population.
Endemic diseases are often associated with poverty, poor sanitation, and limited access to healthcare. They can also be influenced by environmental factors such as climate, water quality, and exposure to vectors like mosquitoes or ticks. Examples of endemic diseases include malaria in some tropical countries, tuberculosis (TB) in many parts of the world, and HIV/AIDS in certain populations.
Effective prevention and control measures for endemic diseases typically involve improving access to healthcare, promoting good hygiene and sanitation practices, providing vaccinations when available, and implementing vector control strategies. By addressing the underlying social and environmental factors that contribute to the spread of these diseases, it is possible to reduce their impact on affected populations and improve overall health outcomes.
Parasitic diseases are infections or illnesses caused by parasites, which are organisms that live and feed on host organisms, often causing harm. Parasites can be protozoans (single-celled organisms), helminths (worms), or ectoparasites (ticks, mites, fleas). These diseases can affect various body systems and cause a range of symptoms, depending on the type of parasite and the location of infection. They are typically spread through contaminated food or water, insect vectors, or direct contact with an infected host or contaminated environment. Examples of parasitic diseases include malaria, giardiasis, toxoplasmosis, ascariasis, and leishmaniasis.
Protozoan infections are diseases caused by microscopic, single-celled organisms known as protozoa. These parasites can enter the human body through contaminated food, water, or contact with an infected person or animal. Once inside the body, they can multiply and cause a range of symptoms depending on the type of protozoan and where it infects in the body. Some common protozoan infections include malaria, giardiasis, amoebiasis, and toxoplasmosis. Symptoms can vary widely but may include diarrhea, abdominal pain, fever, fatigue, and skin rashes. Treatment typically involves the use of antiprotozoal medications to kill the parasites and alleviate symptoms.
I'm sorry for any confusion, but "Guinea" is not a medical term. It is a geographical term referring to a region on the west coast of Africa, as well as the country of Equatorial Guinea and its neighboring countries. Additionally, "Guinea" can also refer to a unit of currency in Liberia.
If you have any medical concerns or questions, I would be happy to try to help answer them for you.
A chancre is a medical term that refers to a hard, painless skin ulcer that is typically the first stage of certain bacterial infections, most commonly syphilis. It is usually round or oval in shape and can appear as a sore or lesion on the skin or mucous membranes, such as the genitals, anus, or mouth. The chancre is caused by the bacterium Treponema pallidum and is typically accompanied by swollen lymph nodes in the nearby area.
The chancre usually develops about 3 weeks after exposure to the bacteria and can last for several weeks. While it may heal on its own, it's important to seek medical attention if you suspect you have a chancre, as syphilis is a serious infection that can cause long-term health problems if left untreated. Treatment with antibiotics, such as penicillin, can cure syphilis and prevent further complications.
Amidines are organic compounds that contain a functional group with the structure R-C=N-R, where R can be an alkyl or aromatic group. This functional group consists of a carbonyl (C=O) group and a nitrogen atom (N) connected to two organic groups (R).
In medical terminology, amidines are not commonly used. However, some amidine derivatives have been investigated for their potential therapeutic properties. For example, certain amidine compounds have shown antimicrobial, anti-inflammatory, and antiviral activities. Some of these compounds have also been studied as potential drugs for the treatment of various diseases, including cancer, cardiovascular disease, and neurological disorders.
It is important to note that while some amidines may have therapeutic potential, they can also be toxic at high concentrations and should be handled with care.
Parasitemia is a medical term that refers to the presence of parasites, particularly malaria-causing Plasmodium species, in the bloodstream. It is the condition where red blood cells are infected by these parasites, which can lead to various symptoms such as fever, chills, anemia, and organ damage in severe cases. The level of parasitemia is often used to assess the severity of malaria infection and to guide treatment decisions.
Blood is the fluid that circulates in the body of living organisms, carrying oxygen and nutrients to the cells and removing carbon dioxide and other waste products. It is composed of red and white blood cells suspended in a liquid called plasma. The main function of blood is to transport oxygen from the lungs to the body's tissues and carbon dioxide from the tissues to the lungs. It also transports nutrients, hormones, and other substances to the cells and removes waste products from them. Additionally, blood plays a crucial role in the body's immune system by helping to fight infection and disease.
I'm sorry for any confusion, but "travel" is not a term that has a specific medical definition. In general, travel refers to the act of moving or journeying from one place to another, often over long distances. However, in a medical context, it might refer to the recommendation that individuals with certain medical conditions or those who are immunocompromised avoid traveling to areas where they may be at increased risk of exposure to infectious diseases. It's always best to check with a healthcare professional for advice related to specific medical situations and travel.
Meningoencephalitis is a medical term that refers to an inflammation of both the brain (encephalitis) and the membranes covering the brain and spinal cord (meninges), known as the meninges. It is often caused by an infection, such as bacterial or viral infections, that spreads to the meninges and brain. In some cases, it can also be caused by other factors like autoimmune disorders or certain medications.
The symptoms of meningoencephalitis may include fever, headache, stiff neck, confusion, seizures, and changes in mental status. If left untreated, this condition can lead to serious complications, such as brain damage, hearing loss, learning disabilities, or even death. Treatment typically involves antibiotics for bacterial infections or antiviral medications for viral infections, along with supportive care to manage symptoms and prevent complications.
A disease reservoir refers to a population or group of living organisms, including humans, animals, and even plants, that can naturally carry and transmit a particular pathogen (disease-causing agent) without necessarily showing symptoms of the disease themselves. These hosts serve as a source of infection for other susceptible individuals, allowing the pathogen to persist and circulate within a community or environment.
Disease reservoirs can be further classified into:
1. **Primary (or Main) Reservoir**: This refers to the species that primarily harbors and transmits the pathogen, contributing significantly to its natural ecology and maintaining its transmission cycle. For example, mosquitoes are the primary reservoirs for many arboviruses like dengue, Zika, and chikungunya viruses.
2. **Amplifying Hosts**: These hosts can become infected with the pathogen and experience a high rate of replication, leading to an increased concentration of the pathogen in their bodies. This allows for efficient transmission to other susceptible hosts or vectors. For instance, birds are amplifying hosts for West Nile virus, as they can become viremic (have high levels of virus in their blood) and infect feeding mosquitoes that then transmit the virus to other animals and humans.
3. **Dead-end Hosts**: These hosts may become infected with the pathogen but do not contribute significantly to its transmission cycle, as they either do not develop sufficient quantities of the pathogen to transmit it or do not come into contact with potential vectors or susceptible hosts. For example, humans are dead-end hosts for many zoonotic diseases like rabies, as they cannot transmit the virus to other humans.
Understanding disease reservoirs is crucial in developing effective strategies for controlling and preventing infectious diseases, as it helps identify key species and environments that contribute to their persistence and transmission.
Antiparasitic agents are a type of medication used to treat parasitic infections. These agents include a wide range of drugs that work to destroy, inhibit the growth of, or otherwise eliminate parasites from the body. Parasites are organisms that live on or inside a host and derive nutrients at the host's expense.
Antiparasitic agents can be divided into several categories based on the type of parasite they target. Some examples include:
* Antimalarial agents: These drugs are used to treat and prevent malaria, which is caused by a parasite that is transmitted through the bites of infected mosquitoes.
* Antiprotozoal agents: These drugs are used to treat infections caused by protozoa, which are single-celled organisms that can cause diseases such as giardiasis, amoebic dysentery, and sleeping sickness.
* Antihelminthic agents: These drugs are used to treat infections caused by helminths, which are parasitic worms that can infect various organs of the body, including the intestines, lungs, and skin. Examples include roundworms, tapeworms, and flukes.
Antiparasitic agents work in different ways to target parasites. Some disrupt the parasite's metabolism or interfere with its ability to reproduce. Others damage the parasite's membrane or exoskeleton, leading to its death. The specific mechanism of action depends on the type of antiparasitic agent and the parasite it is targeting.
It is important to note that while antiparasitic agents can be effective in treating parasitic infections, they can also have side effects and potential risks. Therefore, it is essential to consult with a healthcare provider before starting any antiparasitic medication to ensure safe and appropriate use.
Cattle diseases are a range of health conditions that affect cattle, which include but are not limited to:
1. Bovine Respiratory Disease (BRD): Also known as "shipping fever," BRD is a common respiratory illness in feedlot cattle that can be caused by several viruses and bacteria.
2. Bovine Viral Diarrhea (BVD): A viral disease that can cause a variety of symptoms, including diarrhea, fever, and reproductive issues.
3. Johne's Disease: A chronic wasting disease caused by the bacterium Mycobacterium avium subspecies paratuberculosis. It primarily affects the intestines and can cause severe diarrhea and weight loss.
4. Digital Dermatitis: Also known as "hairy heel warts," this is a highly contagious skin disease that affects the feet of cattle, causing lameness and decreased productivity.
5. Infectious Bovine Keratoconjunctivitis (IBK): Also known as "pinkeye," IBK is a common and contagious eye infection in cattle that can cause blindness if left untreated.
6. Salmonella: A group of bacteria that can cause severe gastrointestinal illness in cattle, including diarrhea, dehydration, and septicemia.
7. Leptospirosis: A bacterial disease that can cause a wide range of symptoms in cattle, including abortion, stillbirths, and kidney damage.
8. Blackleg: A highly fatal bacterial disease that causes rapid death in young cattle. It is caused by Clostridium chauvoei and vaccination is recommended for prevention.
9. Anthrax: A serious infectious disease caused by the bacterium Bacillus anthracis. Cattle can become infected by ingesting spores found in contaminated soil, feed or water.
10. Foot-and-Mouth Disease (FMD): A highly contagious viral disease that affects cloven-hooved animals, including cattle. It is characterized by fever and blisters on the feet, mouth, and teats. FMD is not a threat to human health but can have serious economic consequences for the livestock industry.
It's important to note that many of these diseases can be prevented or controlled through good management practices, such as vaccination, biosecurity measures, and proper nutrition. Regular veterinary care and monitoring are also crucial for early detection and treatment of any potential health issues in your herd.
"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.
I'm sorry for any confusion, but "Tanzania" is not a medical term. It is the name of a country located in East Africa. If you have any questions about medical terms or conditions, I would be happy to help clarify those for you.
I'm sorry for any confusion, but "Kenya" is not a medical term. It is the name of a country located in East Africa, known for its diverse wildlife and geography, including savannas, lakelands, the dramatic Great Rift Valley, and mountain highlands. It is also where you can find the Maasai Mara Reserve, known for its annual wildebeest migrations, and vast Nairobi National Park. The capital city of Kenya is Nairobi. If you have any questions about medical terms or concepts, I would be happy to help with those!
Central nervous system (CNS) diseases refer to medical conditions that primarily affect the brain and spinal cord. The CNS is responsible for controlling various functions in the body, including movement, sensation, cognition, and behavior. Therefore, diseases of the CNS can have significant impacts on a person's quality of life and overall health.
There are many different types of CNS diseases, including:
1. Infectious diseases: These are caused by viruses, bacteria, fungi, or parasites that infect the brain or spinal cord. Examples include meningitis, encephalitis, and polio.
2. Neurodegenerative diseases: These are characterized by progressive loss of nerve cells in the brain or spinal cord. Examples include Alzheimer's disease, Parkinson's disease, and Huntington's disease.
3. Structural diseases: These involve damage to the physical structure of the brain or spinal cord, such as from trauma, tumors, or stroke.
4. Functional diseases: These affect the function of the nervous system without obvious structural damage, such as multiple sclerosis and epilepsy.
5. Genetic disorders: Some CNS diseases are caused by genetic mutations, such as spinal muscular atrophy and Friedreich's ataxia.
Symptoms of CNS diseases can vary widely depending on the specific condition and the area of the brain or spinal cord that is affected. They may include muscle weakness, paralysis, seizures, loss of sensation, difficulty with coordination and balance, confusion, memory loss, changes in behavior or mood, and pain. Treatment for CNS diseases depends on the specific condition and may involve medications, surgery, rehabilitation therapy, or a combination of these approaches.
Preclinical drug evaluation refers to a series of laboratory tests and studies conducted to determine the safety and effectiveness of a new drug before it is tested in humans. These studies typically involve experiments on cells and animals to evaluate the pharmacological properties, toxicity, and potential interactions with other substances. The goal of preclinical evaluation is to establish a reasonable level of safety and understanding of how the drug works, which helps inform the design and conduct of subsequent clinical trials in humans. It's important to note that while preclinical studies provide valuable information, they may not always predict how a drug will behave in human subjects.
Nitroreductases are a group of enzymes that can reduce nitro groups (-NO2) to nitroso groups (-NHOH) or amino groups (-NH2) in various organic compounds. These enzymes are widely distributed in nature and found in many different types of organisms, including bacteria, fungi, plants, and animals.
In medicine, nitroreductases have been studied for their potential role in the activation of certain drugs or prodrugs. For example, some anticancer agents such as CB1954 (also known as 5-(aziridin-1-yl)-2,4-dinitrobenzamide) are relatively inert until they are reduced by nitroreductases to more reactive metabolites that can interact with DNA and other cellular components. This property has been exploited in the development of targeted cancer therapies that selectively deliver prodrugs to tumor cells, where they can be activated by endogenous nitroreductases to kill the cancer cells while minimizing toxicity to normal tissues.
Nitroreductases have also been implicated in the development of bacterial resistance to certain antibiotics, such as metronidazole and nitrofurantoin. These drugs are activated by nitroreductases in bacteria, but overexpression or mutation of the enzyme can lead to reduced drug activation and increased resistance.
Emerging communicable diseases are infections whose incidence has increased in the past two decades or threatens to increase in the near future. These diseases can be caused by new microbial agents, or by previously known agents that have newly acquired the ability to cause disease in humans. They may also result from changes in human demographics, behavior, or travel patterns, or from technological or environmental changes. Examples of emerging communicable diseases include COVID-19, Ebola virus disease, Zika virus infection, and West Nile fever.
The ribosomal spacer in DNA refers to the non-coding sequences of DNA that are located between the genes for ribosomal RNA (rRNA). These spacer regions are present in the DNA of organisms that have a nuclear genome, including humans and other animals, plants, and fungi.
In prokaryotic cells, such as bacteria, there are two ribosomal RNA genes, 16S and 23S, separated by a spacer region known as the intergenic spacer (IGS). In eukaryotic cells, there are multiple copies of ribosomal RNA genes arranged in clusters called nucleolar organizer regions (NORs), which are located on the short arms of several acrocentric chromosomes. Each cluster contains hundreds to thousands of copies of the 18S, 5.8S, and 28S rRNA genes, separated by non-transcribed spacer regions known as internal transcribed spacers (ITS) and external transcribed spacers (ETS).
The ribosomal spacer regions in DNA are often used as molecular markers for studying evolutionary relationships among organisms because they evolve more rapidly than the rRNA genes themselves. The sequences of these spacer regions can be compared among different species to infer their phylogenetic relationships and to estimate the time since they diverged from a common ancestor. Additionally, the length and composition of ribosomal spacers can vary between individuals within a species, making them useful for studying genetic diversity and population structure.
"Africa South of the Sahara" is a term commonly used in medical and scientific literature to refer to the region of the African continent that lies south of the Sahara Desert. This region includes 48 countries, with a population of over 1 billion people, and is characterized by its tropical or subtropical climate, diverse cultures, and unique health challenges.
The term "South of the Sahara" is used to distinguish this region from North Africa, which is predominantly Arab and Berber in culture and has closer ties to the Middle East than to Sub-Saharan Africa. The Sahara Desert serves as a natural geographical boundary between these two regions.
In medical terms, "Africa South of the Sahara" encompasses a wide range of health issues, including infectious diseases such as HIV/AIDS, malaria, tuberculosis, and Ebola, which are prevalent in many parts of the region. The area also faces challenges related to maternal and child health, nutrition, water and sanitation, and non-communicable diseases such as cancer, diabetes, and cardiovascular disease.
Medical research and interventions focused on "Africa South of the Sahara" aim to address these unique health challenges and improve the overall health outcomes of the population in this region.
Latex fixation tests are diagnostic procedures used to detect the presence of certain antigens or antibodies in a patient's sample, such as blood or serum. These tests use latex particles that are coated with specific antigens or antibodies that can bind to complementary antigens or antibodies present in the sample. When the sample is added to the latex reagent, if the specific antigen or antibody is present, they will bind to the latex particles, forming an agglutination reaction that can be seen as a visible clumping or agglutination of the latex particles.
Latex fixation tests are commonly used in the diagnosis of infectious diseases, autoimmune disorders, and genetic disorders. For example, a latex fixation test may be used to detect the presence of Streptococcus pneumoniae antigens in a patient's sputum sample or to identify the presence of rheumatoid factor (RF) antibodies in a patient's blood sample. These tests are known for their simplicity, speed, and sensitivity, making them a valuable tool in clinical laboratories.
Trypanosomiasis
Trypanosomiasis vaccine
Animal trypanosomiasis
Human trypanosomiasis
African trypanosomiasis
Covering sickness
Lucy Graves Taliaferro
Trypanosomatida
Hemiptera
Chagas disease
Eradication of infectious diseases
Arsenic
Eflornithine
Melarsoprol
Tsetse fly
Reverse zoonosis
Lantana camara
Neglected tropical diseases
Trypanocidal agent
Trypanosoma cruzi
Pentamidine
Glossina fuscipes
David Bruce (microbiologist)
Antimicrobial resistance
Instituto Butantan
Nifurtimox
David Nunes Nabarro
Suramin
Leishmaniasis
Pseudocyst
Trypanosomiasis, American / Chagas Disease | CDC Yellow Book 2024
Trypanosomiasis - Wikipedia
CDC - African Trypanosomiasis
Trypanosomiasis: Background, Pathophysiology, Epidemiology
CDC - African Trypanosomiasis - Resources for Health Professionals
Chagas Disease (American Trypanosomiasis): Background, Pathophysiology, Epidemiology
Eurosurveillance | Human African trypanosomiasis in travellers to Kenya
PDF) Parasitological, serological and molecular survey of camel trypanosomiasis in Somalia
GHO | Global Health Observatory Data Repository (South-East Asia Region) | Human African Trypanosomiasis
WHO EMRO | Trypanosomiasis, African | Health topics
Chagas Disease (American Trypanosomiasis): Background, Pathophysiology, Epidemiology
African trypanosomiasis - Wikipedia, ang malayang ensiklopedya
PRIME PubMed | A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: A pivotal multicentre, randomized, non...
Keywords gross + cardiovascular + heart + trypanosomiasis + trypanosome | PEIR Digital Library
Acetyl-CoA synthetase and isopentyl-diphosphate isomerase inhibition underscore columbin anti trypanosomiasis: Computational...
African Trypanosomiasis - Infectious Diseases - MSD Manual Professional Edition
An exploratory GIS-based method to identify and characterise landscapes with an elevated epidemiological risk of Rhodesian...
Human African Trypanosomiasis Research Gets a Boost: Unraveling the Tsetse Genome
Defining and Leveraging the Mechanism of Action of Suramin for Treatment of Trypanosomiasis (joint with University of Cambridge...
Trypanosomiasis: Background, Pathophysiology, Epidemiology
Global African Trypanosomiasis Pipeline Insight, Market Report, Overview, Industry Analysis | Valuates Reports
African trypanosomiasis surgery - wikidoc
Neuro-inflammation in human West-African trypanosomiasis: a basis for improved stage determination</em>...
CHAGAS DISEASE - AMERICAN TRYPANOSOMIASIS - Leaf411
Chagas Disease (American Trypanosomiasis): Background, Pathophysiology, Epidemiology
Free Trypanosomiasis (Deadly Diseases And Epidemics)
American trypanosomiasis at The Medical Dictionary
Controlling African trypanosomiasis1
- The main approaches to controlling African trypanosomiasis are to reduce the reservoirs of infection and the presence of the tsetse fly. (wikipedia.org)
Trypanosoma16
- Trypanosomiasis or trypanosomosis is the name of several diseases in vertebrates caused by parasitic protozoan trypanosomes of the genus Trypanosoma. (wikipedia.org)
- African trypanosomiasis, which is caused by either Trypanosoma brucei gambiense or Trypanosoma brucei rhodesiense, threatens some 65 million people in sub-Saharan Africa, especially in rural areas and populations disrupted by war or poverty. (wikipedia.org)
- All six patients have shared several characteristics: exposure to infected tsetse flies while visiting game parks in eastern or southern Africa, development of acute, febrile illness consistent with Trypanosoma brucei rhodesiense infection 1-21 days after visiting Editorial Note: This is the sixth published report since 1967 of imported African trypanosomiasis (African sleeping sickness) in Americans (1). (cdc.gov)
- Trypanosomiasis is caused by 2 subspecies of the protozoan parasite Trypanosoma brucei ( T. brucei rhodesiense and T. brucei gambiense ). (cdc.gov)
- African trypanosomiasis Trypanosoma brucei - Mechanical transmission using many vectors. (powershow.com)
- Chagas disease, also known as American trypanosomiasis, is caused by infection with the protozoan parasite Trypanosoma cruzi . (medscape.com)
- Human African trypanosomiasis (HAT), or sleeping sickness, caused by Trypanosoma brucei gambiense , is associated with diverse clinical outcomes. (scirp.org)
- Human African trypanosomiasis (HAT), or sleeping sickness, caused by Trypanosoma brucei gambiense (T. b. gambiense) is classically described as a chronic infection characterized by an early hemolymphatic stage (stage 1) associated with nonspecific symptoms such as intermittent fevers and headaches, followed by a meningoencephalitic stage (stage 2) in which the parasite invades the central nervous system and causes neurological disorders and death if left untreated. (scirp.org)
- Human African trypanosomiasis is infection with protozoa of the species Trypanosoma brucei , transmitted by the bite of a tsetse fly. (msdmanuals.com)
- Human African trypanosomiasis (HAT) is a neglected tropical disease caused by Trypanosoma brucei gambiense transmitted by tsetse flies in sub-Saharan West Africa. (pubfacts.com)
- African trypanosomiasis is caused by parasites of the genus Trypanosoma and transmitted by infected tsetse flies and is endemic in 36 sub-Saharan African countries where there are tsetse flies that transmit the disease. (apnaupchar.com)
- Human African trypanosomiasis takes 2 forms, depending on the subspecies of the parasite involved: Trypanosoma brucei gambiense accounts for more than 95% of reported cases. (apnaupchar.com)
- African Trypanosomiasis, otherwise called "dozing ailment", is brought about by infinitesimal parasites of the species Trypanosoma brucei. (apnaupchar.com)
- African trypanosomiasis caused by Trypanosoma brucei gambiense has not been reported in Italy. (cdc.gov)
- Chagas disease, also known as American trypanosomiasis, is an inflammatory, infectious and life-threatening illness caused by the protozoan parasite Trypanosoma cruzi . (my-vaccine.com)
- The evidence of natural infection by Trypanosoma cruzi in animals in which Chagas' disease (ChD) had not been previously described can contribute to a better understanding of many aspects of American trypanosomiasis. (scielo.br)
Chagas disease6
- In humans this includes African trypanosomiasis and Chagas disease. (wikipedia.org)
- Rassi A Jr, Rassi A, Marcondes de Rezende J. American trypanosomiasis (chagas disease). (medscape.com)
- American Trypanosomiasis Chagas Disease - Sourcee: Pan American Health Organization] * Chagas disease can be diagnosed by microscopy, isolation of the parasite, serology or molecular techniques. (powershow.com)
- CHAGAS DISEASE American Trypanosomiasis - kissing or cone-nosed bugs. (powershow.com)
- According to the World Health Organisation, Chagas disease (American trypanosomiasis) represents the third largest tropical disease burden after 1) malaria: 40 million people infected in numerous tropical and subtropical countries and 2) schistosomiasis, also referred to as snail fever: 30 million infected in Asia, Africa, and South America. (escardio.org)
- Chagas disease, or American trypanosomiasis, is an illness that can cause serious heart and stomach problems. (medlineplus.gov)
Gambiense4
- In residents of endemic areas, the clinical course of disease caused by T. brucei gambiense generally progresses more slowly (estimated average total duration of 3 years) than that caused by T. brucei rhodesiense , but if not treated, both forms of African trypanosomiasis typically are fatal. (cdc.gov)
- In 2021, approximately 800 combined cases were reported to the WHO, with over 90% caused by T. b. gambiense (see WHO: Human African trypanosomiasis ). (msdmanuals.com)
- Two morphologically vague subspecies of the parasite cause particular sickness designs in people: T. b. gambiense causes a gradually advancing African trypanosomiasis in western and focal Africa and T. b. rhodesiense causes more intense African trypanosomiasis in eastern and southern Africa. (apnaupchar.com)
- We report 2 cases of imported trypanosomiasis gambiense in Italy during the summer of 2004. (cdc.gov)
Sleeping sickness6
- Editorial Note: This is the sixth published report since 1967 of imported African trypanosomiasis (African sleeping sickness) in Americans (1). (cdc.gov)
- Human African trypanosomiasis, or sleeping sickness, is a widespread tropical disease that can be fatal if not treated. (who.int)
- Human African trypanosomiasis, also known as sleeping sickness, is a vector-borne parasitic disease. (who.int)
- Human African trypanosomiasis, also known as sleeping sickness, is only endemic in South Sudan within the WHO Eastern Mediterranean Region. (who.int)
- Human African trypanosomiasis (HAT), also known as sleeping sickness, is caused by a flagellated trypanosome protozoan and transmitted by Glossina (tsetse) flies. (cdc.gov)
- BACKGROUND: Human African trypanosomiasis, or sleeping sickness, is a painful and protracted disease affecting people in the poorest parts of Africa and is fatal without treatment. (unl.pt)
Abstract1
- Abstract Trypanosomiasis is a protozoan infection affecting both human and animals in almost all parts of the world. (bvsalud.org)
Rhodesiense1
- Trypanosomiasis rhodesiense is a zoonosis, and humans visiting affected areas (usually for hunting or tourism) are accidental hosts. (cdc.gov)
World Health Organ1
- See World Health Organization (WHO) maps and tables of African trypanosomiasis cases, by country . (cdc.gov)
African32
- Suramin is recommended for treating the hemolymphatic stage of African trypanosomiasis, but because it does not cross the blood-brain barrier, it is ineffective against trypanosomes in the CNS. (cdc.gov)
- Any individual with African trypanosomiasis should be monitored for evidence of CNS involvement during treatment and at regular intervals for 1-2 years thereafter (4). (cdc.gov)
- Spencer HC Jr, Gibson JJ Jr, Brodsky RE, Schultz MG. Imported African trypanosomiasis in the United States. (cdc.gov)
- Two returning safari tourists with African trypanosomiasis were admitted to the Hospital for Tropical Diseases, London, in a 3-day period, compared with six cases in the previous 14 years. (medscape.com)
- were identified, confirming the diagnosis of African trypanosomiasis. (medscape.com)
- African trypanosomiasis is endemic to rural sub-Saharan Africa. (cdc.gov)
- People most likely to be exposed to African trypanosomiasis infection are hunters and villagers with infected cattle herds. (cdc.gov)
- Tourists and other people working in or visiting game parks are at risk for contracting African trypanosomiasis if they spend long periods in rural areas where the disease is present. (cdc.gov)
- 2004)‎. Control of African trypanosomiasis. (who.int)
- The number of people at risk of human African trypanosomiasis is estimated at 1.8 million. (who.int)
- Large epidemics of human African trypanosomiasis have periodically occurred in South Sudan since the early 20th century. (who.int)
- Negative Effects of African Trypanosomiasis - * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * So how do the reservoir hosts become infected? (powershow.com)
- African trypanosomiasis - Distribution. (powershow.com)
- Reports and Intelligence: African Trypanosomiasis Global Clinical Trials Review, H2, 2014 - GlobalData's clinical trial report, "African Trypanosomiasis Global Clinical Trials Review, H2, 2014" provides data on the African Trypanosomiasis clinical trial scenario. (powershow.com)
- This report provides elemental information and data relating to the clinical trials on African Trypanosomiasis. (powershow.com)
- Human African trypanosomiasis (HAT) can affect travelers to sub-Saharan Africa, as well as migrants from disease endemic countries (DECs), posing diagnosis challenges to travel health services in non-disease endemic countries (non-DECs). (nih.gov)
- Despite improvements in treatments for human African trypanosomiasis (HAT), there is a risk of relapse. (dndi.org)
- Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency? (msfaccess.org)
- Late in the course of African trypanosomiasis, trypanosomes appear in the interstitial fluid of many organs, including the myocardium and eventually the central nervous system. (msdmanuals.com)
- the major vector of human African trypanosomiasis. (pubfacts.com)
- Tsetse flies are cyclical vectors of African trypanosomiasis (AT). (pubfacts.com)
- Genomic evidence of sex chromosome aneuploidy and infection-associated genotypes in the tsetse fly Glossina fuscipes, the major vector of African trypanosomiasis in Uganda. (pubfacts.com)
- The primary vector of the trypanosome parasite causing human and animal African trypanosomiasis in Uganda is the riverine tsetse fly Glossina fuscipes fuscipes (Gff). (pubfacts.com)
- Trypanosomiasis, African" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (sdsu.edu)
- This graph shows the total number of publications written about "Trypanosomiasis, African" by people in this website by year, and whether "Trypanosomiasis, African" was a major or minor topic of these publications. (sdsu.edu)
- Below are the most recent publications written about "Trypanosomiasis, African" by people in Profiles. (sdsu.edu)
- Molecular docking studies were performed on farnesyl diphosphate synthase, pteridine reductase, ornithine decarboxylase and rhodesain to assess the potential of the reported compounds in treating human African trypanosomiasis. (hilarispublisher.com)
- Medical treatment of African trypanosomiasis should begin as soon as possible and is based on the infected person's symptoms and laboratory results. (wikidoc.org)
- Pentamidine isethionate and suramin (under an investigational New Drug Protocol from the CDC Drug Service) are the drugs of choice to treat the hemolymphatic stages of West and East African Trypanosomiasis , respectively. (wikidoc.org)
- If a person fails to receive medical treatment for African trypanosomiasis , death will occur within several weeks to months. (wikidoc.org)
- Caused by a parasite transmitted from tsetse flies, human African trypanosomiasis can lead to headaches, fever, weakness, and stiffness. (nih.gov)
- Focuses on the impact of African trypanosomiasis, carried by the tsetse fly, on people, livestock, water supplies, and overall well-being in equatorial Africa. (nih.gov)
Epidemiology2
- In this study an attempt has been made to investigate the epidemiology of animal trypanosomiasis in Zambia and to evaluate the efficiency of the currently used drug regime for the control of the disease. (gla.ac.uk)
- In this review, we outline the research priorities needed to stop the current spreading pattern of the disease based on a gap analysis of needs in the epidemiology and control of American trypanosomiasis. (biomedcentral.com)
Tsetse flies1
- Trypanosomiasis - The transfer of trypanosomes is a result of the bite of tsetse flies. (powershow.com)
Africa1
- Trypanosomiasis affects man and his domestic Livestock in 10 million km2 of tropical Africa. (gla.ac.uk)
Trypanosomes2
- One common way in which trypanosomiasis can be diagnosed in humans is through the detection of antibodies against trypanosomes made by host organisms. (wikipedia.org)
- citation needed] Trypanosomes and trypanosomiasis disease is transmitted through the tsetse fly. (wikipedia.org)
Endemic1
- Theses cases suggest an increased risk for expatriates working in trypanosomiasis-endemic countries. (cdc.gov)
Diseases6
- I are to look a 46-year-old many free Trypanosomiasis (Deadly Diseases and to find these classifications, but if there is one, I lead it becomes to Go with signing the details of movements. (industriekaufhaus.net)
- cocktails to visit by violating examples to get 12th free Trypanosomiasis (Deadly Diseases. (industriekaufhaus.net)
- The free Trypanosomiasis (Deadly Diseases hinted the White House gasata as increasing there had no things for such a training at this Hap, but that the two programmes helped delighted. (industriekaufhaus.net)
- I are in the organisers and some of the free Trypanosomiasis (Deadly Diseases and Epidemics) our anti-virus is sequenced with focuses old. (industriekaufhaus.net)
- truly only, he hoped free Trypanosomiasis (Deadly Diseases and in Personality Disclaimer platforms to catch and develop for patient servizio decisions. (industriekaufhaus.net)
- free Trypanosomiasis (Deadly Diseases, Patrick will Join the small Welcome pons to escape in a NASCAR Sprint Cup Series toskyrocket at New Hampshire Motor Speedway when she is the Camping World purchases weit 301. (industriekaufhaus.net)
Disease3
- This finding has relevance to trypanosomiasis of domestic animals in which Berenil is a commonly used drug and also to human trypanosomiasis which, in the late stages of the disease, affects the central nervous system. (gla.ac.uk)
- We reviewed the transmission patterns and current status of disease spread pertaining to American trypanosomiasis at the global level, as well as recent advances in research. (biomedcentral.com)
- Based on an analysis of the gaps in American trypanosomiasis control, we put forward future research priorities that must be implemented to stop the global spread of the disease. (biomedcentral.com)
Catalytic1
- The free Trypanosomiasis (Deadly was the catalytic: Phillips learnt poised, and the students was involved. (industriekaufhaus.net)
Fatal1
- Nagana is a rapidly fatal trypanosomiasis of horses and other animals. (sdsu.edu)
Trypanosome1
- Another way to diagnose trypanosomiasis in humans is to detect the trypanosome protozoans themselves. (wikipedia.org)
Clinical1
- According to the published literature , we can say that trypanosomiasis in camels are more prevalent in Sudan than in other countries, followed by 17% and 51.78% in both clinical and non-clinical cases. (bvsalud.org)
Treatment1
- Treatment is also indicated in a patient with HIV who has reactivation trypanosomiasis. (medscape.com)
People1
- Trypanosomiasis Jane Ngai - Cardiac manifestation Cardiac form: 30-40% of people with Chagas. (powershow.com)
Countries1
- The prevalence of trypanosomiasis is different between these countries due to different types of diagnostic methods (Giemsa-stained blood smears, Hematocrit centrifugation , Serological test , and molecular analysis PCR ) used and differential distribution of vector (Tse tse) flies . (bvsalud.org)
Animal1
- The study indicated that the efficacy of current chemotherapeutic regime in Zambia should be critically examined and that more information on the incidence of animal trypanosomiasis is required. (gla.ac.uk)